Bionano Genomics (BNGO) Other Working Capital Changes (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Other Working Capital Changes data on file, last reported at -$339000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 358.11% year-over-year to -$339000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 306.31% YoY), and the FY2025 full-year result was $2.1 million, up 230.26% from the prior year.
• Other Working Capital Changes declined to -$339000.0 in Q1 2026, from $3.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $7.2 million in Q3 2023 to a low of -$9.0 million in Q4 2023.
• A 5-year average of $124941.2 and a median of $29000.0 in 2025 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 2091.79% in 2023, while the deepest fall reached 386.52% in 2023.
• Tracing BNGO's Other Working Capital Changes over 5 years: stood at $3.1 million in 2022, then sank by 386.52% to -$9.0 million in 2023, then surged by 86.19% to -$1.2 million in 2024, then soared by 345.5% to $3.1 million in 2025, then sank by 111.1% to -$339000.0 in 2026.
• Business Quant data shows BNGO's Other Working Capital Changes at -$339000.0 in Q1 2026, $3.1 million in Q4 2025, and -$947000.0 in Q3 2025.